BSE filing, NSE: ROSSARI. Summary written from the filing by ALFA Finder's alert engine.
Rossari Biotech Ltd: key numbers
- Share price
- ₹407.05
- Market cap
- ₹2,255 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 14.8×Sector 34.1×
- Promoter holding
- 68.14%+0.00% QoQ
- FII holding
- 1.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rossari Biotech Ltd
All →Rossari Biotech Earnings Call Transcript: Key Takeaways
Rossari Biotech achieved record quarterly revenue and EBITDA despite volatile raw material costs and logistical headwinds.
- Call
- Guides 15% growth
Rossari Biotech Results Update
Rossari Biotech reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% YoY. The company also announced plans for a new manufacturing facility in Saudi Arabia.
Rossari Biotech Investor Presentation: Key Takeaways
Rossari Biotech reported record quarterly revenue of Rs. 697.6 Cr (up 19% YoY) and EBITDA of Rs. 87 Cr (up 21% YoY). Performance driven by volume and product mix.
Rossari Biotech Q2 FY27 Results: Net Profit ₹38.9 Cr, Up 5.4% YoY
Rossari Biotech Ltd reported revenue from operations of ₹697.6 Cr (+19.0% YoY) and net profit of ₹38.9 Cr (+5.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38.9 Cr · +5.4% YoY
Rossari Biotech Other Announcement
Rossari Biotech submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes minor reporting adjustments for two promoter group members.
Rossari Biotech Board Meeting Date
Rossari Biotech will hold a board meeting on October 17, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Other board meeting date announcements
All →GTV Engineering Board Meeting Date
GTV Engineering scheduled a Board Meeting for 5 November 2026 to approve unaudited Q2 and half-year financial results. No new information is disclosed beyond the meeting notice.
Elixir Capital Board Meeting Date
Elixir Capital Ltd notified BSE that its Board will meet on 6 Nov 2026 to consider Q2/H1FY27 results. No financial figures or decisions are reported yet.
Ecofinity Atomix Board Meeting Date
Ecofinity Atomix Ltd intimated BSE of a Board meeting on 7 November 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are stated.
Gorani Industries Board Meeting Date
Gorani Industries scheduled its Board meeting for 13 November 2026. It will consider the unaudited results for the September quarter and half-year.
Luxury Time Board Meeting Date
Luxury Time Ltd scheduled its board meeting for 3 Nov 2026 to consider H1 results, CFO replacement, and director remuneration. The filing is a prior intimation; no decisions have been made yet.
India Cements Capital Board Meeting Date
India Cements Capital Ltd scheduled its Audit Committee and Board meeting for 5 Nov 2026 to approve unaudited Q1/H1 FY27 results. Trading window remains closed until results publication on 7 Nov 2026.